• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Corium poised for $66M IPO for wearable drug-delivery devices

March 24, 2014 By drugdelivery

Corium poised for $66M IPO for wearable drug-delivery devices

Drug-delivery devices maker Corium could raise up to $66 million through an initial public offering, the company announced in SEC filings today.

Corium plans to offer 5.5 million shares of common stock for $10-$12 apiece, putting its total offering value at between $55-$66 million. At the middle rate of $11 per share, Corium expects its net proceeds to amount to $53.7 million after expenses.

The Menlo Park, Calif., company manufactures wearable drug-delivery systems, including a set of Crest Advanced Seal Whitestrips. Other products include the company’s MicroCor needle-free large molecule delivery system and Corplex "steady state" small molecule delivery system. Existing partners include Procter & Gamble Co., Par Pharmaceutical, Teva Pharmaceuticals USA and Agile Therapeutics.

Corium plans to use the proceeds from the IPO to scale up production and pursue Phase II studies for the MicroCor products, further develop the Corplex products, repurchase about $5.2 million in shares and pay for general corporate activities, according to its IPO registration documents.

The company posted about $13.9 million in losses on $50.2 million in revenue for fiscal 2013. The stock will trade on the NASDAQ global market under the symbol "CORI."

Filed Under: Drug-Device Combinations Tagged With: Corium

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS